Our CTO Yutaro Kyono will speak at the “Message from a Venture Companies Online Corporate Matching in Shinkawa […]
Our CEO Ryu Ogawa will speak about Drug Development at the CPhI Japan Webinar on Nov 13, 14:15 JST. 11月13日開催の中 […]
We are excited to announce that MOLCURE will be exhibiting at Bio Japan 2020! MOLCUREはBioJapan2020に出展します。 Link […]
We ranked 1st in Artificial Intelligence at the Shenzhen Advanced Technology Pitch Contest Japan Qualifying To […]
MOLCURE participated in the 1st Shenzhen Advanced Technology Pitch Contest Japan Qualifying Tournament. 第1回 深セ […]
Our CEO Dr. Ryu Ogawa and CSO Dr. Satoshi Tamaki were interviewed by Pharma Boardroom about MOLCURE’s impact i […]
The recent Plug and Play Japan’s Kyoto-Batch 1 EXPO on the theme of “Hardtech & Health” provided exce […]
Molcure CEO Ryu Ogawa and CSO Satoshi Tamaki talk to @VoicesofLeaders about how AI will transform the field of […]
The Ministry of Economy, Trade & Industry includes MOLCURE in its case studies for team building, highligh […]
Due to business expansion, MOLCURE is moving its head office from Shinagawa to Kawasaki and will be based in t […]